Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 148 entries
Sorted by: Best Match Show Resources per page
Mild Cognitive Impairment and Dementia Prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS).

Alzheimer's & dementia (Amsterdam, Netherlands)

Knopman DS, Gottesman RF, Sharrett AR, Wruck LM, Windham BG, Coker L, Schneider AL, Hengrui S, Alonso A, Coresh J, Albert MS, Mosley TH.
PMID: 26949733
Alzheimers Dement (Amst). 2016;2:1-11. doi: 10.1016/j.dadm.2015.12.002.

INTRODUCTION: We examined prevalence of mild cognitive impairment (MCI) and dementia in the Atherosclerosis Risk in Communities (ARIC) Neurocognitive Study.METHODS: Beginning in June, 2011, we invited all surviving ARIC participants to undergo cognitive, neurological and brain imaging assessments to...

Cite
Knopman DS, Gottesman RF, Sharrett AR, et al. Mild Cognitive Impairment and Dementia Prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS). Alzheimers Dement (Amst). 2016;2:1-11doi: 10.1016/j.dadm.2015.12.002.
Knopman, D. S., Gottesman, R. F., Sharrett, A. R., Wruck, L. M., Windham, B. G., Coker, L., Schneider, A. L., Hengrui, S., Alonso, A., Coresh, J., Albert, M. S., & Mosley, T. H. (2016). Mild Cognitive Impairment and Dementia Prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS). Alzheimer's & dementia (Amsterdam, Netherlands), 21-11. https://doi.org/10.1016/j.dadm.2015.12.002
Knopman, David S, et al. "Mild Cognitive Impairment and Dementia Prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS)." Alzheimer's & dementia (Amsterdam, Netherlands) vol. 2 (2016): 1-11. doi: https://doi.org/10.1016/j.dadm.2015.12.002
Knopman DS, Gottesman RF, Sharrett AR, Wruck LM, Windham BG, Coker L, Schneider AL, Hengrui S, Alonso A, Coresh J, Albert MS, Mosley TH. Mild Cognitive Impairment and Dementia Prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS). Alzheimers Dement (Amst). 2016;2:1-11. doi: 10.1016/j.dadm.2015.12.002. PMID: 26949733; PMCID: PMC4772876.
Copy Download .nbib Format: NLM
Technical note: how to determine the FDG activity for tumour PET imaging that satisfies European guidelines.

EJNMMI physics

Koopman D, van Osch JA, Jager PL, Tenbergen CJ, Knollema S, Slump CH, van Dalen JA.
PMID: 27682837
EJNMMI Phys. 2016 Dec;3(1):22. doi: 10.1186/s40658-016-0158-z. Epub 2016 Sep 29.

BACKGROUND: For tumour imaging with PET, the literature proposes to administer a patient-specific FDG activity that depends quadratically on a patient's body weight. However, a practical approach on how to implement such a protocol in clinical practice is currently...

Cite
Koopman D, van Osch JA, Jager PL, et al. Technical note: how to determine the FDG activity for tumour PET imaging that satisfies European guidelines. EJNMMI Phys. 2016;3(1):22doi: 10.1186/s40658-016-0158-z.
Koopman, D., van Osch, J. A., Jager, P. L., Tenbergen, C. J., Knollema, S., Slump, C. H., & van Dalen, J. A. (2016). Technical note: how to determine the FDG activity for tumour PET imaging that satisfies European guidelines. EJNMMI physics, 3(1), 22. https://doi.org/10.1186/s40658-016-0158-z
Koopman, Daniëlle, et al. "Technical note: how to determine the FDG activity for tumour PET imaging that satisfies European guidelines." EJNMMI physics vol. 3,1 (2016): 22. doi: https://doi.org/10.1186/s40658-016-0158-z
Koopman D, van Osch JA, Jager PL, Tenbergen CJ, Knollema S, Slump CH, van Dalen JA. Technical note: how to determine the FDG activity for tumour PET imaging that satisfies European guidelines. EJNMMI Phys. 2016 Dec;3(1):22. doi: 10.1186/s40658-016-0158-z. Epub 2016 Sep 29. PMID: 27682837; PMCID: PMC5040656.
Copy Download .nbib Format: NLM
Contributions of imprecision in PET-MRI rigid registration to imprecision in amyloid PET SUVR measurements.

Human brain mapping

Schwarz CG, Jones DT, Gunter JL, Lowe VJ, Vemuri P, Senjem ML, Petersen RC, Knopman DS, Jack CR.
PMID: 28432784
Hum Brain Mapp. 2017 Jul;38(7):3323-3336. doi: 10.1002/hbm.23622. Epub 2017 Apr 22.

Quantitative measurement of β-amyloid from amyloid PET scans typically relies on localizing target and reference regions by image registration to MRI. In this work, we present a series of simulations where 50 small random perturbations of starting location and...

Cite
Schwarz CG, Jones DT, Gunter JL, et al. Contributions of imprecision in PET-MRI rigid registration to imprecision in amyloid PET SUVR measurements. Hum Brain Mapp. 2017;38(7):3323-3336doi: 10.1002/hbm.23622.
Schwarz, C. G., Jones, D. T., Gunter, J. L., Lowe, V. J., Vemuri, P., Senjem, M. L., Petersen, R. C., Knopman, D. S., Jack, C. R. (2017). Contributions of imprecision in PET-MRI rigid registration to imprecision in amyloid PET SUVR measurements. Human brain mapping, 38(7), 3323-3336. https://doi.org/10.1002/hbm.23622
Schwarz, Christopher G, et al. "Contributions of imprecision in PET-MRI rigid registration to imprecision in amyloid PET SUVR measurements." Human brain mapping vol. 38,7 (2017): 3323-3336. doi: https://doi.org/10.1002/hbm.23622
Schwarz CG, Jones DT, Gunter JL, Lowe VJ, Vemuri P, Senjem ML, Petersen RC, Knopman DS, Jack CR. Contributions of imprecision in PET-MRI rigid registration to imprecision in amyloid PET SUVR measurements. Hum Brain Mapp. 2017 Jul;38(7):3323-3336. doi: 10.1002/hbm.23622. Epub 2017 Apr 22. PMID: 28432784; PMCID: PMC5518286.
Copy Download .nbib Format: NLM
Choosing an appropriate bacterial typing technique for epidemiologic studies.

Epidemiologic perspectives & innovations : EP+I

Foxman B, Zhang L, Koopman JS, Manning SD, Marrs CF.
PMID: 16309556
Epidemiol Perspect Innov. 2005 Nov 25;2:10. doi: 10.1186/1742-5573-2-10.

A wide variety of bacterial typing systems are currently in use that vary greatly with respect to the effort required, cost, reliability and ability to discriminate between bacterial strains. No one technique is optimal for all forms of investigation....

Cite
Foxman B, Zhang L, Koopman JS, et al. Choosing an appropriate bacterial typing technique for epidemiologic studies. Epidemiol Perspect Innov. 2005;2:10doi: 10.1186/1742-5573-2-10.
Foxman, B., Zhang, L., Koopman, J. S., Manning, S. D., & Marrs, C. F. (2005). Choosing an appropriate bacterial typing technique for epidemiologic studies. Epidemiologic perspectives & innovations : EP+I, 210. https://doi.org/10.1186/1742-5573-2-10
Foxman, Betsy, et al. "Choosing an appropriate bacterial typing technique for epidemiologic studies." Epidemiologic perspectives & innovations : EP+I vol. 2 (2005): 10. doi: https://doi.org/10.1186/1742-5573-2-10
Foxman B, Zhang L, Koopman JS, Manning SD, Marrs CF. Choosing an appropriate bacterial typing technique for epidemiologic studies. Epidemiol Perspect Innov. 2005 Nov 25;2:10. doi: 10.1186/1742-5573-2-10. PMID: 16309556; PMCID: PMC1308839.
Copy Download .nbib Format: NLM
Commentary: "Treatment of hypertension and prevention of dementia" by Oliver Hanon and Françoise Forette.

Alzheimer's & dementia : the journal of the Alzheimer's Association

Knopman D.
PMID: 19595815
Alzheimers Dement. 2005 Jul;1(1):41-2. doi: 10.1016/j.jalz.2005.06.024.

No abstract available.

Cite
Knopman D. Commentary: "Treatment of hypertension and prevention of dementia" by Oliver Hanon and Françoise Forette. Alzheimers Dement. 2005;1(1):41-2doi: 10.1016/j.jalz.2005.06.024.
Knopman, D. (2005). Commentary: "Treatment of hypertension and prevention of dementia" by Oliver Hanon and Françoise Forette. Alzheimer's & dementia : the journal of the Alzheimer's Association, 1(1), 41-2. https://doi.org/10.1016/j.jalz.2005.06.024
Knopman, David. "Commentary: "Treatment of hypertension and prevention of dementia" by Oliver Hanon and Françoise Forette." Alzheimer's & dementia : the journal of the Alzheimer's Association vol. 1,1 (2005): 41-2. doi: https://doi.org/10.1016/j.jalz.2005.06.024
Knopman D. Commentary: "Treatment of hypertension and prevention of dementia" by Oliver Hanon and Françoise Forette. Alzheimers Dement. 2005 Jul;1(1):41-2. doi: 10.1016/j.jalz.2005.06.024. PMID: 19595815.
Copy Download .nbib Format: NLM
WITHDRAWN: What makes them split? Identifying risk factors that lead to monozygotic twins after in vitro fertilization.

Fertility and sterility

Knopman JM, Krey LC, Oh C, Lee J, McCaffrey C, Noyes N.
PMID: 24112530
Fertil Steril. 2013 Oct 07; doi: 10.1016/j.fertnstert.2013.08.053. Epub 2013 Oct 07.

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

Cite
Knopman JM, Krey LC, Oh C, et al. WITHDRAWN: What makes them split? Identifying risk factors that lead to monozygotic twins after in vitro fertilization. Fertil Steril. 2013;doi: 10.1016/j.fertnstert.2013.08.053.
Knopman, J. M., Krey, L. C., Oh, C., Lee, J., McCaffrey, C., & Noyes, N. (2013). WITHDRAWN: What makes them split? Identifying risk factors that lead to monozygotic twins after in vitro fertilization. Fertility and sterility, . https://doi.org/10.1016/j.fertnstert.2013.08.053
Knopman, Jaime M, et al. "WITHDRAWN: What makes them split? Identifying risk factors that lead to monozygotic twins after in vitro fertilization." Fertility and sterility vol. (2013). doi: https://doi.org/10.1016/j.fertnstert.2013.08.053
Knopman JM, Krey LC, Oh C, Lee J, McCaffrey C, Noyes N. WITHDRAWN: What makes them split? Identifying risk factors that lead to monozygotic twins after in vitro fertilization. Fertil Steril. 2013 Oct 07; doi: 10.1016/j.fertnstert.2013.08.053. Epub 2013 Oct 07. PMID: 24112530.
Copy Download .nbib Format: NLM
Practice issues in neurology.

Continuum (Minneapolis, Minn.)

Knopman DS.
PMID: 22810291
Continuum (Minneap Minn). 2010 Apr;16(2):228-30. doi: 10.1212/01.CON.0000368227.26739.54.

No abstract available.

Cite
Knopman DS. Practice issues in neurology. Continuum (Minneap Minn). 2010;16(2):228-30doi: 10.1212/01.CON.0000368227.26739.54.
Knopman, D. S. (2010). Practice issues in neurology. Continuum (Minneapolis, Minn.), 16(2), 228-30. https://doi.org/10.1212/01.CON.0000368227.26739.54
Knopman, David S. "Practice issues in neurology." Continuum (Minneapolis, Minn.) vol. 16,2 (2010): 228-30. doi: https://doi.org/10.1212/01.CON.0000368227.26739.54
Knopman DS. Practice issues in neurology. Continuum (Minneap Minn). 2010 Apr;16(2):228-30. doi: 10.1212/01.CON.0000368227.26739.54. PMID: 22810291.
Copy Download .nbib Format: NLM
Rates of lobar atrophy in asymptomatic .

Alzheimer's & dementia (New York, N. Y.)

Chen Q, Boeve BF, Senjem M, Tosakulwong N, Lesnick TG, Brushaber D, Dheel C, Fields J, Forsberg L, Gavrilova R, Gearhart D, Graff-Radford J, Graff-Radford NR, Jack CR, Jones DT, Knopman DS, Kremers WK, Lapid M, Rademakers R, Syrjanen J, Boxer AL, Rosen H, Wszolek ZK, Kantarci K.
PMID: 31388560
Alzheimers Dement (N Y). 2019 Jul 30;5:338-346. doi: 10.1016/j.trci.2019.05.010. eCollection 2019.

RESULTS: The rate of temporal lobe atrophy in asymptomatic DISCUSSION: Accelerated decline in temporal lobe volume occurs in asymptomatic

Cite
Chen Q, Boeve BF, Senjem M, et al. Rates of lobar atrophy in asymptomatic . Alzheimers Dement (N Y). 2019;5:338-346doi: 10.1016/j.trci.2019.05.010.
Chen, Q., Boeve, B. F., Senjem, M., Tosakulwong, N., Lesnick, T. G., Brushaber, D., Dheel, C., Fields, J., Forsberg, L., Gavrilova, R., Gearhart, D., Graff-Radford, J., Graff-Radford, N. R., Jack, C. R., Jones, D. T., Knopman, D. S., Kremers, W. K., Lapid, M., Rademakers, R., Syrjanen, J., Boxer, A. L., Rosen, H., Wszolek, Z. K., Kantarci, K. (2019). Rates of lobar atrophy in asymptomatic . Alzheimer's & dementia (New York, N. Y.), 5338-346. https://doi.org/10.1016/j.trci.2019.05.010
Chen, Qin, et al. "Rates of lobar atrophy in asymptomatic ." Alzheimer's & dementia (New York, N. Y.) vol. 5 (2019): 338-346. doi: https://doi.org/10.1016/j.trci.2019.05.010
Chen Q, Boeve BF, Senjem M, Tosakulwong N, Lesnick TG, Brushaber D, Dheel C, Fields J, Forsberg L, Gavrilova R, Gearhart D, Graff-Radford J, Graff-Radford NR, Jack CR, Jones DT, Knopman DS, Kremers WK, Lapid M, Rademakers R, Syrjanen J, Boxer AL, Rosen H, Wszolek ZK, Kantarci K. Rates of lobar atrophy in asymptomatic . Alzheimers Dement (N Y). 2019 Jul 30;5:338-346. doi: 10.1016/j.trci.2019.05.010. eCollection 2019. PMID: 31388560; PMCID: PMC6675939.
Copy Download .nbib Format: NLM
The Telephone Interview for Cognitive Status.

Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology

Knopman DS.
PMID: 30239467
Cogn Behav Neurol. 2018 Sep;31(3):158. doi: 10.1097/WNN.0000000000000166.

No abstract available.

Cite
Knopman DS. The Telephone Interview for Cognitive Status. Cogn Behav Neurol. 2018;31(3):158doi: 10.1097/WNN.0000000000000166.
Knopman, D. S. (2018). The Telephone Interview for Cognitive Status. Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 31(3), 158. https://doi.org/10.1097/WNN.0000000000000166
Knopman, David S. "The Telephone Interview for Cognitive Status." Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology vol. 31,3 (2018): 158. doi: https://doi.org/10.1097/WNN.0000000000000166
Knopman DS. The Telephone Interview for Cognitive Status. Cogn Behav Neurol. 2018 Sep;31(3):158. doi: 10.1097/WNN.0000000000000166. PMID: 30239467.
Copy Download .nbib Format: NLM
An Innovative Interactive Modeling Tool to Analyze Scenario-Based Physician Workforce Supply and Demand.

Academic pathology

Gupta S, Black-Schaffer WS, Crawford JM, Gross D, Karcher DS, Kaufman J, Knapman D, Prystowsky MB, Wheeler TM, Bean S, Kumar P, Sharma R, Chamoli V, Ghai V, Gogia V, Weintraub S, Cohen MB, Robboy SJ.
PMID: 28725751
Acad Pathol. 2015 Oct 13;2(4):2374289515606730. doi: 10.1177/2374289515606730. eCollection 2015.

Effective physician workforce management requires that the various organizations comprising the House of Medicine be able to assess their current and future workforce supply. This information has direct relevance to funding of graduate medical education. We describe a dynamic...

Cite
Gupta S, Black-Schaffer WS, Crawford JM, et al. An Innovative Interactive Modeling Tool to Analyze Scenario-Based Physician Workforce Supply and Demand. Acad Pathol. 2015;2(4):2374289515606730doi: 10.1177/2374289515606730.
Gupta, S., Black-Schaffer, W. S., Crawford, J. M., Gross, D., Karcher, D. S., Kaufman, J., Knapman, D., Prystowsky, M. B., Wheeler, T. M., Bean, S., Kumar, P., Sharma, R., Chamoli, V., Ghai, V., Gogia, V., Weintraub, S., Cohen, M. B., & Robboy, S. J. (2015). An Innovative Interactive Modeling Tool to Analyze Scenario-Based Physician Workforce Supply and Demand. Academic pathology, 2(4), 2374289515606730. https://doi.org/10.1177/2374289515606730
Gupta, Saurabh, et al. "An Innovative Interactive Modeling Tool to Analyze Scenario-Based Physician Workforce Supply and Demand." Academic pathology vol. 2,4 (2015): 2374289515606730. doi: https://doi.org/10.1177/2374289515606730
Gupta S, Black-Schaffer WS, Crawford JM, Gross D, Karcher DS, Kaufman J, Knapman D, Prystowsky MB, Wheeler TM, Bean S, Kumar P, Sharma R, Chamoli V, Ghai V, Gogia V, Weintraub S, Cohen MB, Robboy SJ. An Innovative Interactive Modeling Tool to Analyze Scenario-Based Physician Workforce Supply and Demand. Acad Pathol. 2015 Oct 13;2(4):2374289515606730. doi: 10.1177/2374289515606730. eCollection 2015. PMID: 28725751; PMCID: PMC5479464.
Copy Download .nbib Format: NLM
Measuring cognition and function in the preclinical stage of Alzheimer's disease.

Alzheimer's & dementia (New York, N. Y.)

Weintraub S, Carrillo MC, Farias ST, Goldberg TE, Hendrix JA, Jaeger J, Knopman DS, Langbaum JB, Park DC, Ropacki MT, Sikkes SAM, Welsh-Bohmer KA, Bain LJ, Brashear R, Budur K, Graf A, Martenyi F, Storck MS, Randolph C.
PMID: 29955653
Alzheimers Dement (N Y). 2018 Feb 13;4:64-75. doi: 10.1016/j.trci.2018.01.003. eCollection 2018.

The Alzheimer's Association's Research Roundtable met in November 2016 to explore how best to measure changes in cognition and function in the preclinical stage of Alzheimer's disease. This review will cover the tools and instruments currently available to identify...

Cite
Weintraub S, Carrillo MC, Farias ST, et al. Measuring cognition and function in the preclinical stage of Alzheimer's disease. Alzheimers Dement (N Y). 2018;4:64-75doi: 10.1016/j.trci.2018.01.003.
Weintraub, S., Carrillo, M. C., Farias, S. T., Goldberg, T. E., Hendrix, J. A., Jaeger, J., Knopman, D. S., Langbaum, J. B., Park, D. C., Ropacki, M. T., Sikkes, S. A. M., Welsh-Bohmer, K. A., Bain, L. J., Brashear, R., Budur, K., Graf, A., Martenyi, F., Storck, M. S., & Randolph, C. (2018). Measuring cognition and function in the preclinical stage of Alzheimer's disease. Alzheimer's & dementia (New York, N. Y.), 464-75. https://doi.org/10.1016/j.trci.2018.01.003
Weintraub, Sandra, et al. "Measuring cognition and function in the preclinical stage of Alzheimer's disease." Alzheimer's & dementia (New York, N. Y.) vol. 4 (2018): 64-75. doi: https://doi.org/10.1016/j.trci.2018.01.003
Weintraub S, Carrillo MC, Farias ST, Goldberg TE, Hendrix JA, Jaeger J, Knopman DS, Langbaum JB, Park DC, Ropacki MT, Sikkes SAM, Welsh-Bohmer KA, Bain LJ, Brashear R, Budur K, Graf A, Martenyi F, Storck MS, Randolph C. Measuring cognition and function in the preclinical stage of Alzheimer's disease. Alzheimers Dement (N Y). 2018 Feb 13;4:64-75. doi: 10.1016/j.trci.2018.01.003. eCollection 2018. PMID: 29955653; PMCID: PMC6021264.
Copy Download .nbib Format: NLM
Sublingual sufentanil for postoperative pain relief: first clinical experiences.

Journal of pain research

Meijer F, Cornelissen P, Sie C, Wagemans M, Mars A, Hobma T, Niesters M, Dahan A, Koopman JS, Steegers MA.
PMID: 29872335
J Pain Res. 2018 May 24;11:987-992. doi: 10.2147/JPR.S160091. eCollection 2018.

BACKGROUND: The sublingual sufentanil tablet system (SSTS) is a novel hand-held patient-controlled analgesia device developed for treatment of moderate-to-severe postoperative pain. Here we present the first results of its clinical use.METHODS: Adult patients undergoing major surgery in five hospitals...

Cite
Meijer F, Cornelissen P, Sie C, et al. Sublingual sufentanil for postoperative pain relief: first clinical experiences. J Pain Res. 2018;11:987-992doi: 10.2147/JPR.S160091.
Meijer, F., Cornelissen, P., Sie, C., Wagemans, M., Mars, A., Hobma, T., Niesters, M., Dahan, A., Koopman, J. S., & Steegers, M. A. (2018). Sublingual sufentanil for postoperative pain relief: first clinical experiences. Journal of pain research, 11987-992. https://doi.org/10.2147/JPR.S160091
Meijer, Fleur, et al. "Sublingual sufentanil for postoperative pain relief: first clinical experiences." Journal of pain research vol. 11 (2018): 987-992. doi: https://doi.org/10.2147/JPR.S160091
Meijer F, Cornelissen P, Sie C, Wagemans M, Mars A, Hobma T, Niesters M, Dahan A, Koopman JS, Steegers MA. Sublingual sufentanil for postoperative pain relief: first clinical experiences. J Pain Res. 2018 May 24;11:987-992. doi: 10.2147/JPR.S160091. eCollection 2018. PMID: 29872335; PMCID: PMC5973446.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 148 entries